フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
VANCOUVER, British Columbia and BOSTON, July 15, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...
VANCOUVER, British Columbia and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...
VANCOUVER, British Columbia and BOSTON, June 11, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...
VANCOUVER, British Columbia and BOSTON, June 03, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...
VANCOUVER, British Columbia and BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...
VANCOUVER, British Columbia and BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB:...
New name reflects evolution of company from development-stage biotech to innovator in predictive medicine TORONTO, Sept. 27...
CDN$10 million/US$8.2 million financing positions IMI for future anticipated growth TORONTO, Aug. 30 /PRNewswire-FirstCall/ -- Predictive...
Enters into agreement for CDN$10 million/US$8.2 million TORONTO, Aug. 18 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International...
- Major ColorectAlert(TM) study with U.S. National Cancer Institute - 25,000-participant PREPARE study underway in life insurance testing market...
Allstate teams up with IMI and McNeil Consumer Healthcare for non-invasive risk assessments TORONTO, Aug. 2 /PRNewswire-FirstCall/ -- Blood...
New data validates PREVU(x) LT Skin Sterol Test Lab-processed format of PREVU(x) reliably measures skin sterol TORONTO, July 26...
Skin sterol linked to history of coronary events TORONTO, July 25 /PRNewswire-FirstCall/ -- Skin tissue cholesterol is strongly associated with...
IMI announces major clinical trial with ColorectAlert(TM) - Sponsored by U.S. National Cancer Institute's EDRN - Patented painless, low-cost...
IMI comments on market activity and Prevu(x) progress TORONTO, June 30 /PRNewswire-FirstCall/ -- In response to recent trading activity in the...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約